Biotech entity

MedPage Today

Company

Every one of those 1 sits in a single category, clinical-trial. MedPage Today is most often covered alongside COSMOS Trial, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention MedPage Today, all published on March 9, 2026.

Last mentioned: Mar 17, 2026

Entity pulse

Recent coverage · MedPage Today

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about MedPage Today

Every one of those 1 sits in a single category, clinical-trial. MedPage Today is most often covered alongside COSMOS Trial, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention MedPage Today, all published on March 9, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering MedPage Today. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Biological Aging Analysis

    New data reveals daily multivitamins significantly slow epigenetic aging clocks.

  2. Cognitive & Clinical Results

    Initial findings on memory and cardiovascular outcomes published with mixed results.

  3. COSMOS Trial Launch

    Large-scale randomized trial begins investigating cocoa extract and multivitamins.

Stories mentioning MedPage Today 1

Clinical Trials Positive

COSMOS Trial: Daily Multivitamins Significantly Slow Biological Aging Clocks

A prespecified analysis of the large-scale COSMOS trial has found that daily multivitamin-multimineral supplementation significantly slows markers of biological aging in older adults. The study provides robust clinical evidence that standard nutritional interventions can influence cellular longevity and epigenetic health beyond simple deficiency prevention.

2 sources

MedPage Today is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.